Description: Medios AG, together with its subsidiaries, supplies specialty pharmaceutical drugs primarily in Germany. It operates through Pharmaceutical Supply and Patient-Specific Therapies segments. The Pharmaceutical Supply segment offers products on oncology, neurology, autoimmunology, ophthalmology, infectiology, and hemophilia diseases. The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies. This segment includes cytostatic infusion preparations, antibody therapies, virostatic and antibiotic medications, parenteral nutrition solutions, and investigational medicinal products. Medios AG was founded in 2016 and is headquartered in Berlin, Germany.
Home Page: www.medios.ag
Heidestrasse 9
Berlin,
10557
Germany
Phone:
49 30 232 5668 00
Officers
| Name | Title |
|---|---|
| Dr. Yann Samson | Chairman of Supervisory Board & Sustainability Officer |
| Mr. Matthias Gaertner | CEO & Chairman of the Executive Board |
| Mr. Falk Neukirch | CFO & Member of Executive Board |
| Mr. Christoph Prußeit | Chief Innovation Officer & Member of Executive Board |
| Ms. Mi-Young Miehler | COO & Member of Executive Board |
| Mr. Constantijn van Rietschoten | Chief of International Markets & Member of Executive Board |
| Claudia Nickolaus | Head of Investor & Public Relations |
Exchange: PINK
Country: US : United States of America
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Health Care Equipment & Services |
| GIC Industry: | Health Care Providers & Services |
| GIC Sub-Industry: | Health Care Distributors |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 73.5294 |
| Price-to-Book MRQ: | 3.2472 |
| Price-to-Sales TTM: | 0.7361 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 333 |